Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
B1307 SJB3-019ATarget: USPSummary: Usp1 inhibitor -
B2151 STF-62247Target: AutophagySummary: Autophagy inducer in renal cell -
B1397 Trifluoperazine 2HClSummary: Dopamine D2 receptor inhibitor -
B1395 Sulfacetamide SodiumSummary: Sulfonamide antibiotic -
B1391 Divalproex SodiumSummary: Epilepsy/migraines/bipolar disorder medicine -
B5567 SMER 3Summary: yeast SCF family E3 ubiquitin ligase (SCFMet30) inhibitor -
B5797 PRT 4165Summary: Bmi1/Ring1A-mediated ubiquitination inhibitor -
B4755 PI-1840Summary: Chymotrypsin-like (CT-L) inhibitor -
B5550 HBX 41108Summary: ubiquitin-specific protease (USP) 7 inhibitor -
A8883 SAR40533 CitationSummary: Selective ATP-competitive inhibitor of Vps34

